Company / Total Assets
PULSE BIOSCIENCES, INC. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$94.5M
FY2025
5-year range
$54.2M / $132.5M
FY2021-FY2025
Trend
-28.6%
vs FY2024
Sector context
#160 of 161
Health Care
What the data says
Among 161 Health Care companies, PULSE BIOSCIENCES, INC. is in the bottom 1% for total assets. Total Assets has fluctuated over the past 10 years, ranging from $26M in FY2016 to $132M in FY2024.
Based on SEC 10-K filings.
$95M in FY2025 with a 5-year CAGR of +18.0%.
Improved from $59M to $95M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +6.7%
- 5-Year CAGR
- +18.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 161This company $94.5M Sector average $14.8B
▼
-99.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +18.0%, indicating consistent growth.
- In FY2025, total assets decreased 28.6% year-over-year.
- Ranks #160 out of 161 companies in the Health Care sector.
- Peak total assets was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $94.5M | -28.6% |
| FY2024 | $132.5M | +123.9% |
| FY2023 | $59.2M | -24.0% |
| FY2022 | $77.9M | +43.6% |
| FY2021 | $54.2M | +31.4% |
| FY2020 | $41.3M | -1.5% |
| FY2019 | $41.9M | -40.7% |
| FY2018 | $70.6M | +41.8% |
| FY2017 | $49.8M | +89.3% |
| FY2016 | $26.3M | +83.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026